Your session is about to expire
← Back to Search
Sucralfate for Esophagitis
Study Summary
This trial will investigate ways to prevent and reduce radiation esophagitis symptoms, and look at their impact on weight loss.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I cannot take Sucralfate as advised by my doctor.My esophagus radiation dose is within the specified range.You have received at least 15% (10-14 fractions) of the prescribed dose.My esophageal radiation dose is within the specified range.I am currently using opioid painkillers before starting radiation therapy.I am 18 years old or older.I am receiving chest radiation that is considered high-risk for my esophagus.My esophagus has been exposed to a certain level of radiation.I am 18 years old or older.My treatment plan includes a specific dose of radiation over 25-35 sessions.My treatment plan includes a specific radiation dose.
- Group 1: One Stage Consent
- Group 2: Two Stage Consent
- Group 3: Sucralfate
- Group 4: Usual Care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What potential hazards could result from the Two Stage Consent process?
"Bearing in mind that this is a Phase 2 trial, our team at Power appraised the safety of Two Stage Consent as a score of two due to the presence of data confirming its security yet lacking evidence for efficacy."
How many participants are registered for this medical trial?
"Verified. Clinicaltrials.gov confirms that this investigation, which was established on December 13th 2022, is currently accepting applicants. Approximately 352 participants need to be enrolled from 7 research sites."
Are there any vacancies left for individuals to partake in this clinical trial?
"Affirmative. According to clinicaltrials.gov, this medical study is actively welcoming participants who fulfill the criteria for enrolment. The trial was first posted on December 13th 2022 and has been recently updated with no changes as of that same date; 352 patients are being sought from 7 different sites across the country."
In what locations can participants access this trial?
"Patients are being recruited for this clinical trial at the Memorial Sloan Kettering Monmouth (All Protocol Activities) in Middletown, Memorial Sloan Kettering Bergen (All Protocol Activities) in Montvale, and Memorial Sloan Kettering Suffolk-Commack (All Protocol Activites) in Commack as well as 7 other sites."
Share this study with friends
Copy Link
Messenger